http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106543208-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F1-08 |
| filingDate | 2016-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106543208-B |
| titleOfInvention | Using 1 pyridine β carbolines as copper chloride (II) chelate of ligand and its synthetic method and application |
| abstract | The invention discloses a kind of using 1 pyridine β carbolines as copper chloride (II) chelate of ligand and its synthetic method and application.Shown in the structural formula such as following formula (I) of copper chloride (II) chelate, its preparation method is：Take compound and Copper dichloride dihydrate as shown in following formula (II), be dissolved in polar solvent, carry out complexation reaction, to obtain the final product.Copper chloride (II) chelate of the present invention is shown than ligand and the stronger antitumor activity of cis-platinum, is had preferable potential medical value, is expected to be used for the preparation of various antitumor drugs.Structure shown in formula (I) and formula (II) is as follows： |
| priorityDate | 2016-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.